Last updated on April 24, 2014 at 17:35 EDT

BIOSAFE Targets Latin American Expansion

December 12, 2013

EYSINS, Switzerland, December 12, 2013 /PRNewswire/ –

Following the set-up of a Shanghai-based Chinese subsidiary and its recent expansion
in India, Biosafe is demonstrating its firm commitment to emerging markets with the
creation of a new subsidiary and the opening today of a new office covering the Latin
American area.

http://photos.prnewswire.com/prnh/20131028/648200 )

The new company, Biosafe do Brasil Participaçôes e Representações Ltda., based in
the Vila Olímpia quarter of São Paulo Brazil, will provide support to Biosafe’s existing
distributors in the region, covering the markets of Brazil, Mexico, Argentina and
Colombia. The office is also tasked with expanding the business into other promising Latin
American countries.

A formal event to commemorate the opening of the new office will be held today at the
Hotel Gran Estanplaza São Paulo, with a conference on cord blood and transplantation that
will include a keynote presentation from Dr. Joanne Kurzberg (Director, Pediatric Blood
and Marrow Transplant Program Duke University and Director, Carolinas Cord Blood Bank).

Commenting on the opening of the new Latin American office, Claude Fell, Biosafe’s
Founder and Chairman of the Board, remarked: “The opening of this new office is an
integral part of our expansion in emerging economies and demonstrates our belief in the
development potential of Latin America. We look forward to working closely with our
clients and scientific partners and to expanding our activities in the region.”

About the Biosafe Group

Founded in 1997 the Biosafe Group is active in the design, manufacture and marketing
of automated cell processing systems. Headquartered in Switzerland and privately-owned,
the Biosafe Group operates through regional subsidiaries (Geneva, Houston, Hong-Kong,
Shanghai and São Paulo) and is present in more than 45 countries, either directly or
through distributors.

For further information:

        Christopher Bolton
        Biosafe Group SA




SOURCE Biosafe Group

Source: PR Newswire